215 related articles for article (PubMed ID: 35565216)
41. CT radiomics for differentiating fat poor angiomyolipoma from clear cell renal cell carcinoma: Systematic review and meta-analysis.
Dehghani Firouzabadi F; Gopal N; Hasani A; Homayounieh F; Li X; Jones EC; Yazdian Anari P; Turkbey E; Malayeri AA
PLoS One; 2023; 18(7):e0287299. PubMed ID: 37498830
[TBL] [Abstract][Full Text] [Related]
42. Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.
Nazari M; Shiri I; Hajianfar G; Oveisi N; Abdollahi H; Deevband MR; Oveisi M; Zaidi H
Radiol Med; 2020 Aug; 125(8):754-762. PubMed ID: 32193870
[TBL] [Abstract][Full Text] [Related]
43. Radiogenomic Predictors of Recurrence in Glioblastoma-A Systematic Review.
Corr F; Grimm D; Saß B; Pojskić M; Bartsch JW; Carl B; Nimsky C; Bopp MHA
J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330402
[TBL] [Abstract][Full Text] [Related]
44. Emerging role of radiogenomics in genetically triggered thoracic aortic aneurysm and dissection: a narrative review.
Lum RTW; Wang X; Zhang M; Zhang X; Ho JYK; Chow SCY; Fujikawa T; Wong RHL
Ann Transl Med; 2023 Aug; 11(10):356. PubMed ID: 37675315
[TBL] [Abstract][Full Text] [Related]
45. Radiogenomics in Interventional Oncology.
Moussa AM; Ziv E
Curr Oncol Rep; 2021 Jan; 23(1):9. PubMed ID: 33387095
[TBL] [Abstract][Full Text] [Related]
46. Computed Tomography Radiomics for Predicting Pathological Grade of Renal Cell Carcinoma.
Yi X; Xiao Q; Zeng F; Yin H; Li Z; Qian C; Wang C; Lei G; Xu Q; Li C; Li M; Gong G; Zee C; Guan X; Liu L; Chen BT
Front Oncol; 2020; 10():570396. PubMed ID: 33585193
[TBL] [Abstract][Full Text] [Related]
47. Radiomics and gene expression profile to characterise the disease and predict outcome in patients with lung cancer.
Kirienko M; Sollini M; Corbetta M; Voulaz E; Gozzi N; Interlenghi M; Gallivanone F; Castiglioni I; Asselta R; Duga S; Soldà G; Chiti A
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3643-3655. PubMed ID: 33959797
[TBL] [Abstract][Full Text] [Related]
48. Next-Generation Radiogenomics Sequencing for Prediction of EGFR and KRAS Mutation Status in NSCLC Patients Using Multimodal Imaging and Machine Learning Algorithms.
Shiri I; Maleki H; Hajianfar G; Abdollahi H; Ashrafinia S; Hatt M; Zaidi H; Oveisi M; Rahmim A
Mol Imaging Biol; 2020 Aug; 22(4):1132-1148. PubMed ID: 32185618
[TBL] [Abstract][Full Text] [Related]
49. Radiogenomics in head and neck cancer: correlation of radiomic heterogeneity and somatic mutations in TP53, FAT1 and KMT2D.
Zwirner K; Hilke FJ; Demidov G; Socarras Fernandez J; Ossowski S; Gani C; Thorwarth D; Riess O; Zips D; Schroeder C; Welz S
Strahlenther Onkol; 2019 Sep; 195(9):771-779. PubMed ID: 31123786
[TBL] [Abstract][Full Text] [Related]
50. Preoperative CT Radiomics Predicting the SSIGN Risk Groups in Patients With Clear Cell Renal Cell Carcinoma: Development and Multicenter Validation.
Jiang Y; Li W; Huang C; Tian C; Chen Q; Zeng X; Cao Y; Chen Y; Yang Y; Liu H; Bo Y; Luo C; Li Y; Zhang T; Wang R
Front Oncol; 2020; 10():909. PubMed ID: 32850304
[No Abstract] [Full Text] [Related]
51. Radiomics and Radiogenomics in Preclinical Imaging on Murine Models: A Narrative Review.
Monti S; Truppa ME; Albanese S; Mancini M
J Pers Med; 2023 Jul; 13(8):. PubMed ID: 37623455
[TBL] [Abstract][Full Text] [Related]
52. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
He H; Jin Z; Dai J; Wang H; Sun J; Xu D
Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
[TBL] [Abstract][Full Text] [Related]
53. Identifying BAP1 Mutations in Clear-Cell Renal Cell Carcinoma by CT Radiomics: Preliminary Findings.
Feng Z; Zhang L; Qi Z; Shen Q; Hu Z; Chen F
Front Oncol; 2020; 10():279. PubMed ID: 32185138
[TBL] [Abstract][Full Text] [Related]
54. Deep learning, radiomics and radiogenomics applications in the digital breast tomosynthesis: a systematic review.
Hussain S; Lafarga-Osuna Y; Ali M; Naseem U; Ahmed M; Tamez-Peña JG
BMC Bioinformatics; 2023 Oct; 24(1):401. PubMed ID: 37884877
[TBL] [Abstract][Full Text] [Related]
55. CT-based transformer model for non-invasively predicting the Fuhrman nuclear grade of clear cell renal cell carcinoma.
Yang M; He X; Xu L; Liu M; Deng J; Cheng X; Wei Y; Li Q; Wan S; Zhang F; Wu L; Wang X; Song B; Liu M
Front Oncol; 2022; 12():961779. PubMed ID: 36249050
[TBL] [Abstract][Full Text] [Related]
56. Radiomics-based machine learning model to predict risk of death within 5-years in clear cell renal cell carcinoma patients.
Nazari M; Shiri I; Zaidi H
Comput Biol Med; 2021 Feb; 129():104135. PubMed ID: 33254045
[TBL] [Abstract][Full Text] [Related]
57. Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy.
Zhang C; Li Y; Qian J; Zhu Z; Huang C; He Z; Zhou L; Gong Y
Front Immunol; 2022; 13():1020729. PubMed ID: 36479115
[TBL] [Abstract][Full Text] [Related]
58. Development of a Multiparametric Renal CT Algorithm for Diagnosis of Clear Cell Renal Cell Carcinoma Among Small (≤ 4 cm) Solid Renal Masses.
Al Nasibi K; Pickovsky JS; Eldehimi F; Flood TA; Lavallee LT; Tsampalieros AK; Schieda N
AJR Am J Roentgenol; 2022 Nov; 219(5):814-823. PubMed ID: 35766532
[No Abstract] [Full Text] [Related]
59. Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.
Ferro M; Musi G; Marchioni M; Maggi M; Veccia A; Del Giudice F; Barone B; Crocetto F; Lasorsa F; Antonelli A; Schips L; Autorino R; Busetto GM; Terracciano D; Lucarelli G; Tataru OS
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902045
[TBL] [Abstract][Full Text] [Related]
60. Computed Tomography-Based Radiomics Model for Predicting the WHO/ISUP Grade of Clear Cell Renal Cell Carcinoma Preoperatively: A Multicenter Study.
Wang R; Hu Z; Shen X; Wang Q; Zhang L; Wang M; Feng Z; Chen F
Front Oncol; 2021; 11():543854. PubMed ID: 33718124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
